|
|
800/850 Ridgeview Drive
Horsham, PA 19044 USA
phone:(610) 651-6000
fax:(610) 651-6100
|
|
| Symbol |
JNJ |
| Exchange |
NYSE |
| Founded |
0 |
| Employees |
|
|
|
| www.centocor.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Biopharmaceutical therapies for cardiovascular, immunologic disorders and cancer. |
|
| Management |
|
| |
|
|
|
|
|
|
|
| Keywords |
| cardiovascular, immunologic disorders, cancer, biopharmaceutical therapies, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohns disease, ulcerative colitis, psoriasis, asthma |
|
|
|
| Description |
|
Centocor creates, acquires and markets biopharmaceutical therapies. Their products focus on the management of three major disease areas: cardiovascular, immunologic disorders and cancer. |
|
| Products / Services |
The following are disease categories and conditions Centocor has developed or is currently developing therapies for: Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, and Asthma
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
